Acquisition of a new plate reader

The Food and Drug Administration is planning the acquisition of a new plate reader, classified under the NAICS code 339113, which pertains to medical device manufacturing. This forecasted contract, posted on March 11, 2026, aims to enhance the agency’s laboratory capabilities through the procurement of advanced equipment. While specific location details for the place of performance are not provided, the acquisition process is managed by the FDA, with a program point of contact available via email for further inquiries. Key organizational roles involved in this acquisition include a dedicated Program Point of Contact named Cvm Acquisition Liaison and a Contracting Officer position yet to be determined. The contract is currently in the forecast stage, indicating initial planning and solicitation phases, with no set-aside type or description mentioned, suggesting an open competition. Interested parties may access further information through the FDA’s industry opportunity forecast portal.